Current Neuro-Oncology
Volume
25 Number 13
15 July 2023
Home > Publications > Current Neuro-Oncology > Volume 25, Year 2023 > Number 13, 15 July
Chatha G, Dhaliwal T, Castle-Kirszbaum MD, Amukotuwa S, Lai L,
Kwan E.
The utility of arterial spin
labelled perfusion-weighted magnetic resonance imaging in
measuring the vascularity of high grade gliomas - A prospective
study.
Heliyon. 2023
Jul 3;9(7):e17615∟.
doi: 10.1016/j.heliyon.2023.e17615∟.
PMID: 37519684∟.
Observational study. ˍ
Hung ND, Dung LV, Vi NH, Hai Anh NT, Hong Phuong LT, Hieu ND, Duc
NM.
The role of 3-Tesla magnetic
resonance perfusion and spectroscopy in distinguishing
glioblastoma from solitary brain metastasis.
J
Clin Imaging Sci. 2023 Jul 3;13:19∟.
doi: 10.25259/JCIS_49_2023∟.
PMID: 37559877∟.
Observational study. ˍ
Martínez Camblor L, Peña Suárez JM,
Martínez-Cachero García M, Santamarta Liébana
E, Rodríguez Castro J, Saiz Ayala A.
Cerebral
microbleeds. Utility of SWI sequences.
Radiologia
(Engl Ed). 2023 Jul 3;65(4):362-375∟.
doi: 10.1016/j.rxeng.2022.12.006∟.
PMID: 37516489∟.
Observational study˰ ˍ
*
Takahashi S, Miyake K, Ogawa D, Anada M, Kinoshita T, Nishide T,
Shibata T.
A Prospective Study of
Intensity-modulated Radiation Therapy Using a Standard Radiation
Dose for High-grade Glioma.
Cancer
Diagn Progn. 2023 Jul 3;3(4):491-497∟.
doi: 10.21873/cdp.10245∟.
PMID: 37405214∟.
Interventional study∟.
ˍ
Tanrıkulu B, Yaşar AH, Canpolat C, Çorapçıoğlu
F, Tezcanli E, Abacioglu U, Danyeli AE, Özek MM.
Preliminary
findings of German-sourced ONC201 treatment in H3K27 altered
pediatric pontine diffuse midline gliomas.
J
Neurooncol. 2023 Jul 4∟.
doi: 10.1007/s11060-023-04347-x∟.
PMID: 37402093∟.
Observational study˰ ˍ
Zhou Z, Yuan J, Chen H, Zhan LP, Sun EY, Chen B.
Prognostic
nomogram for glioblastoma (GBM) patients presenting with distant
extension: a seer-based study.
J
Cancer Res Clin Oncol. 2023 Jul 4∟.
doi: 10.1007/s00432-023-05049-7∟.
PMID: 37401940∟.
Observational study˰ ˍ
*
Guo X, Gu L, Li Y, Zheng Z, Chen W, Wang Y, Wang Y, Xing H, Shi Y,
Liu D, Yang T, Xia Y, Li J, Wu J, Zhang K, Liang T, Wang H, Liu Q,
Jin S, Qu T, Guo S, Li H, Wang Y, Ma W.
Histological
and molecular glioblastoma, IDH-wildtype: a real-world landscape
using the 2021 WHO classification of central nervous system
tumors.
Front Oncol.
2023 Jul 6;13:1200815∟.
doi: 10.3389/fonc.2023.1200815∟.
PMID: 37483487∟.
Observational study. ˍ
Kouli O, McLoone P, Morrison D, Zaorsky NG, Chalmers AJ.
Risk
of stroke-specific mortality after radiotherapy in patients with
primary brain tumours.
Clin
Transl Radiat Oncol. 2023 Jul 6;42:100658∟.
doi: 10.1016/j.ctro.2023.100658∟.
PMID: 37502698∟.
Observational study. ˍ
Yin J, Yin W, Zheng L, Li Y, Luo C, Zhang S, Duan L, Zhou H, Cheng
K, Lang J, Xu K.
Anlotinib as
Monotherapy or Combination Therapy for Recurrent High-Grade
Glioma: A Retrospective Study.
Clin
Med Insights Oncol. 2023 Jul 6;17:11795549231175714∟.
doi: 10.1177/11795549231175714∟.
PMID: 37435019∟.
Observational study. ˍ
Adhikari S, Bhutada AS, Ladner L, Cuoco JA, Entwistle JJ, Marvin
EA, Rogers CM.
Prognostic indicators
for H3K27M-mutant diffuse midline glioma: a population-based
retrospective Surveillance, Epidemiology, and End Results database
analysis.
World
Neurosurg. 2023 Jul 7:S1878-8750(23)00930-0∟.
doi: 10.1016/j.wneu.2023.07.001∟.
PMID: 37423332∟.
Observational study˰ ˍ
Chicard M, Iddir Y, Masliah Planchon J, Combaret V, Attignon V,
Saint-Charles A, Frappaz D, Faure-Conter C, Beccaria K, Varlet P,
Geoerger B, Baulande S, Pierron G, Bouchoucha Y, Doz F, Delattre
O, Waterfall JJ, Bourdeaut F, Schleiermacher G.
Cell-Free
DNA Extracted from CSF for the Molecular Diagnosis of Pediatric
Embryonal Brain Tumors.
Cancers
(Basel). 2023 Jul 7;15(13):3532∟.
doi: 10.3390/cancers15133532∟.
PMID: 37444642∟.
Observational
study. ˍ
Di Carlo D, Annereau M, Yoldjian I, Vassal G, Grill J.
An
academia-driven compassionate use program for patients with
recurrent H3K27-altered diffuse midline glioma: a new way to
access innovation when clinical trials are lacking.
Ann
Oncol. 2023 Jul 7:S0923-7534(23)00761-5∟.
doi: 10.1016/j.annonc.2023.06.012∟.
PMID: 37423297∟.
Expanded access study˰ ˍ
Laprie A, Noel G, Chaltiel L, Truc G, Sunyach MP, Charissoux M,
Magne N, Auberdiac P, Biau J, Ken S, Tensaouti F, Khalifa J,
Sidibe I, Roux FE, Vieillevigne L, Catalaa I, Boetto S, Emmanuelle
UC, Supiot S, Bernier V, Filleron T, Mounier M, Poublanc M,
Olivier P, Delord JP, Cohen-Jonathan-Moyal E.
Randomized
phase III trial of metabolic imaging-guided dose escalation of
radio-chemotherapy in patients with newly diagnosed glioblastoma
(SPECTRO GLIO trial).
Neuro
Oncol. 2023 Jul 7:noad119∟.
doi: 10.1093/neuonc/noad119∟.
PMID: 37417948∟.
Interventional study˰ ˍ
Muthukrishnan SD, Qi H, Wang D, Elahi L, Pham A, Alvarado AG, Li
T, Gao F, Kawaguchi R, Lai A, Kornblum HI.
Low-
and high-grade glioma endothelial cells differentially regulate
tumor growth.
bioRxiv
[Preprint]. 2023 Jul 7:2023.07.07.548125∟.
doi: 10.1101/2023.07.07.548125∟.
PMID: 37461434∟.
Laboratory investigation. ˍ
Natukka T, Haapasalo J, Kivioja T, Rajala L, Raitanen J,
Nevalainen J, Lahtela SL, Nordfors K, Rauhala M, Jukkola A, Frösen
J, Helén P, Auvinen A, Haapasalo H.
Impact
of timing of surgery and adjuvant treatment on survival of adult
IDH-wildtype glioblastoma: a single-center study of 392
patients.
World
Neurosurg. 2023 Jul 7:S1878-8750(23)00933-6∟.
doi: 10.1016/j.wneu.2023.07.008∟.
PMID: 37423335∟.
Observational
study. ˍ
Sattiraju A, Kang S, Giotti B, Chen Z, Marallano VJ, Brusco C,
Ramakrishnan A, Shen L, Tsankov AM, Hambardzumyan D, Friedel RH,
Zou H.
Hypoxic niches attract and
sequester tumor-associated macrophages and cytotoxic T cells and
reprogram them for immunosuppression.
Immunity.
2023 Jul 7:S1074-7613(23)00274-1∟.
doi: 10.1016/j.immuni.2023.06.017∟.
PMID: 37451265∟.
Laboratory investigation˰ ˍ
Trivedi AG, Ramesh KK, Huang V, Mellon EA, Barker PB, Kleinberg
LR, Weinberg BD, Shu HG, Shim H.
Spectroscopic
MRI-Based Biomarkers Predict Survival for Newly Diagnosed
Glioblastoma in a Clinical Trial.
Cancers
(Basel). 2023 Jul 7;15(13):3524∟.
doi: 10.3390/cancers15133524∟.
PMID: 37444634∟.
Observational
study. ˍ
Ye Kahng J, Kang BH, Lee ST, Hong Choi S, Min Kim T, Park CK, Won
JK, Park SH, Son J, Ho Lee J.
Clinicogenetic
characteristics and the effect of radiation on the neural stem
cell niche in subventricular zone-contacting
glioblastoma.
Radiother
Oncol. 2023 Jul 7:109800∟.
doi: 10.1016/j.radonc.2023.109800∟.
PMID: 37423479∟.
Observational
study˰ ˍ
Hönikl LS, Lange N, Meyer B, Gempt J, Meyer HS.
Postoperative
Communicating Hydrocephalus Following Grade 2/3 Glioma Resection:
Incidence, Timing and Risk Factors.
Cancers
(Basel). 2023 Jul 9;15(14):3548∟.
doi: 10.3390/cancers15143548∟.
PMID: 37509211∟.
Observational study. ˍ
+*
Baviskar Y, Likonda B, Pant S, Mokal S, Pawar A, Dasgupta A,
Chatterjee A, Gupta T.
Short-course
Palliative Hypofractionated Radiotherapy in Patients with
Poor-prognosis High-grade Glioma: Survival and Quality of Life
Outcomes from a Prospective Phase II Study.
Clin
Oncol (R Coll Radiol). 2023 Jul 10:S0936-6555(23)00240-6∟.
doi: 10.1016/j.clon.2023.07.001∟.
PMID: 37455146∟.
Interventional study˰ ˍ
*
Halaj M, Kalita O, Tuckova L, Hrabalek L, Dolezel M, Vrbkova
J.
Life expectancy in glioblastoma
patients who had undergone stereotactic biopsy: a retrospective
single-center study.
Biomed Pap Med Fac Univ Palacky
Olomouc Czech Repub. 2023 Jul 10∟.
doi: 10.5507/bp.2023.030∟.
PMID: 37431620∟.
Observational
study. ˍ
Otsuji R, Hata N, Funakoshi Y, Kuga D, Togao O, Hatae R,
Sangatsuda Y, Fujioka Y, Takigawa K, Sako A, Kikuchi K, Yoshitake
T, Yamamoto H, Mizoguchi M, Yoshimoto K.
Supramaximal
Resection Can Prolong the Survival of Patients with Cortical
Glioblastoma: A Volumetric Study.
Neurol
Med Chir (Tokyo). 2023 Jul 10∟.
doi: 10.2176/jns-nmc.2022-0351∟.
PMID: 37423755∟.
Observational
study. ˍ
Scheer M, Spindler K, Strauss C, Schob S, Dietzel CT, Leisz S,
Prell J, Rampp S.
Surgical Site
Infections in Glioblastoma Patients-A Retrospective Analysis.
J
Pers Med. 2023 Jul 10;13(7):1117∟.
doi: 10.3390/jpm13071117∟.
PMID: 37511730∟.
Observational study. ˍ
Liu X, Wang Y, Wang Y, Zhao J, Shi W, Zhao Y, Chen L, Wu
L.
Associations between adiposity,
diabetes, lifestyle factors and the risk of gliomas.
Front
Med (Lausanne). 2023 Jul 11;10:1207223∟.
doi: 10.3389/fmed.2023.1207223∟.
PMID: 37497279∟.
Observational study. ˍ
Zhang Z, Wu Y, Zhao X, Zhou J, Li L, Zhai X, Liang P.
The
insertion and management of an external ventricular drain in
pediatric patients with hydrocephalus associated with
medulloblastoma.
Neurosurg
Rev. 2023 Jul 11;46(1):170∟.
doi: 10.1007/s10143-023-02080-7∟.
PMID: 37433938∟.
Observational study˰ ˍ
*
Currie S, Fatania K, Frood R, Whitehead R, Start J, Lee MT,
McDonald B, Rankeillor K, Roberts P, Chakrabarty A, Mathew RK,
Murray L, Short S, Scarsbrook A.
Imaging
Spectrum of the Developing Glioblastoma: A Cross-Sectional
Observation Study.
Curr
Oncol. 2023 Jul 13;30(7):6682-6698∟.
doi: 10.3390/curroncol30070490∟.
PMID: 37504350∟.
Observational study. ˍ
Ilic I, Ilic M.
International patterns
and trends in the brain cancer incidence and mortality: An
observational study based on the global burden of
disease.
Heliyon. 2023
Jul 13;9(7):e18222∟.
doi: 10.1016/j.heliyon.2023.e18222∟.
PMID: 37519769∟.
Observational study. ˍ
Matsui JK, Allen PK, Perlow HK, Johnson JM, Paulino AC, McAleer
MF, Fouladi M, Grosshans DR, Ghia AJ, Li J, Zaky WT, Chintagumpala
MM, Palmer JD, McGovern SL.
Prognostic
factors for pediatric, adolescent, and young adult patients with
non-DIPG grade 4 gliomas: a contemporary pooled institutional
experience.
J
Neurooncol. 2023 Jul 13∟.
doi: 10.1007/s11060-023-04386-4∟.
PMID: 37440097∟.
Observational
study˰ ˍ
*
Somlyai G, Kovács BZ, Papp A, Somlyai I.
A Preliminary
Study Indicating Improvement in the Median Survival Time of
Glioblastoma Multiforme Patients by the Application of Deuterium
Depletion in Combination with Conventional Therapy.
Biomedicines.
2023 Jul 13;11(7):1989∟.
doi: 10.3390/biomedicines11071989∟.
PMID: 37509628∟.
Observational study. ˍ
Ballal S, Yadav MP, Raju S, Roesch F, Martin M, Tripathi M, Bal
C.
[177Lu]Lu-DOTAGA.Glu.(FAPi)2
Radionuclide Therapy: a New Treatment Option for Patients with
Glioblastoma Multiforme.
Nucl
Med Mol Imaging. 2023 Jul 14;58(1):32-34. doi:
10.1007/s13139-023-00814-5?. PMID:
38261876. Case report˰
ˍ
Bao Z, Li S, Wang L, Zhang B, Zhang P, Shi H, Qiu X, Jiang
T.
PTPRZ1-METFUsion GENe (ZM-FUGEN)
trial: study protocol for a multicentric, randomized, open-label
phase II/III trial.
Chin
Neurosurg J. 2023 Jul 14;9(1):21∟.
doi: 10.1186/s41016-023-00329-0∟.
PMID: 37443050∟.
Interventional study protocol. ˍ
Kang HJ, Kim M, Kwak YK, Shin J, Lee SJ.
Reduced
volume intensity-modulated radiotherapy with simultaneous
integrated boost for patients with high-grade glioma: A
retrospective observational study.
Medicine
(Baltimore). 2023 Jul 14;102(28):e33955∟.
doi: 10.1097/MD.0000000000033955?.
PMID: 37443476∟.
Observational
study. ˍ
Cao W, Xiong L, Meng L, Li Z, Hu Z, Lei H, Wu J, Song T, Liu C,
Wei R, Shen L, Hong J.
Prognostic
analysis and nomogram construction for older patients with
IDH-wild-type glioblastoma.
Heliyon.
2023 Jul 15;9(7):e18310∟.
doi: 10.1016/j.heliyon.2023.e18310∟.
PMID: 37519736∟.
Observational study. ˍ
Mallick S, Gupta S, Amariyil A, Kunhiparambath H, Laviraj MA,
Sharma S, Sagiraju HKR, Julka PK, Sharma D, Rath
GK.
Hypo-fractionated accelerated
radiotherapy with concurrent and maintenance temozolomide in newly
diagnosed glioblastoma: updated results from phase II HART-GBM
trial.
J Neurooncol.
2023 Jul 15∟.
doi: 10.1007/s11060-023-04391-7∟.
PMID: 37452916∟.
Interventional study˰ ˍ